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Glutamate-cysteine ligase (GCL) plays an important
role in regulating glutathione homeostasis. In mammals,
it comprises a catalytic (GCLC) and modifier (GCLM)
subunit. The existence of a modifier subunit in inverte-
brates has not been described to date. We now demon-
strate that GCL from Drosophila melanogaster has a
functional modifier subunit (DmGCLM). A putative
DmGCLM was obtained as an expressed sequence tag
with 27% identity to human GCLM at the amino acid
level. D. melanogaster GCLC (DmGCLC) and the candi-
date DmGCLM were expressed separately in Esche-
richia coli, purified, mixed, and then subjected to gel
filtration, where they eluted as an 140-kDa complex.
DmGCLC co-immunoprecipitated with DmGCLM from
S2 cell extracts, suggesting that they also associate in
vivo. Enzyme kinetic analyses showed that DmGCLC has
a Km for glutamate of 2.88 mM, but when complexed with
DmGCLM, the Km for glutamate is 0.45 mM. Inhibition of
DmGCLC activity by glutathione was found to be com-
petitive with respect to glutamate (Ki  0.03 mM),
whereas inhibition of the GCL complex was mixed (Ki 
0.67 mM), suggesting allosteric effects. In accordance
with this, DmGCLC and DmGCLM have the ability to
form reversible intermolecular disulfide bridges. A fur-
ther mechanism for control of D. melanogaster GCL was
found to be induction of DmGCLC by tert-butylhydro-
quinone in S2 cells. DmGCLM levels were, however, un-
affected by tert-butylhydroquinone.
Cellular injury from reactive oxygen species and electrophilic
agents is inhibited by glutathione, an abundant and essential
tripeptide thiol. Despite the critical importance of glutathione
for virtually all aerobically respiring cells, relatively little is
known about how cells regulate glutathione homeostasis. It is
apparent, however, that a key player in the control of glutathi-
one synthesis is glutamate-cysteine ligase (GCL,1 EC 6.3.2.2,
-glutamylcysteine synthetase), which catalyzes the first reac-
tion in the two-step pathway for de novo synthesis. The ulti-
mate enzyme in the pathway, glutathione synthetase, does not
appear to play such an important part in the fine-tuning of
cellular redox status. GCL activity seems to be regulated by
cellular thiol antioxidant balance, and in mammals, this con-
trol mechanism is principally mediated by a non-catalytic
polypeptide (GCLM) that dimerizes with the catalytic subunit
of GCL (GCLC) (1, 2).
Native and recombinant GCLs from rat and human have been
extensively characterized (1–4). It has been shown that GCL
from these species comprises an 73-kDa catalytic subunit and
an 31-kDa regulatory subunit. GCLC has all of the catalytic
activity, but in vitro experiments with rat kidney GCL suggested
that, unless complexed with GCLM, it has exquisite sensitivity to
feedback inhibition by glutathione and a high Km (18 mM) for
glutamate (2). Combination with GCLM caused the Ki for gluta-
thione to be substantially increased and the Km for glutamate to
be reduced by 13-fold. The presence of reducing agents caused the
Km for glutamate to increase by2-fold and increased the extent
of inhibition by the glutathione analog ophthalmic acid, suggest-
ing that GCLM may regulate GCLC activity in response to the
immediate redox environment. Based on the in vitro data, it has
been proposed that rat GCLC would not be functional in vivo
without the presence of GCLM (1).
Although GCLM seems to have an important role in regu-
lating glutathione synthesis, to date, only GCL from verte-
brates has been shown to have a functional regulatory subunit.
GCL from Escherichia coli is distinct from the eukaryotic forms
described so far and is a monomer with a subunit molecular
mass of 58 kDa (5). Interestingly, the E. coli GCL amino acid
sequence has a greater level of identity to GCLM than to GCLC
(1). Catalytic subunits of GCL from Saccharomyces cerevisiae
and Caenorhabditis elegans have been identified (6, 7), and
although they are structurally related to human GCLC (32 and
54% identities at the amino acid level, respectively), there are
no convincing candidate genes in the data base with compara-
ble levels of sequence identity to GCLM. GCL from Trypano-
soma brucei has been cloned and its enzyme activity rigorously
characterized (8, 9). Although T. brucei GCL shares 45% se-
quence identity at the amino acid level with mammalian
GCLC, the kinetic data are highly suggestive that T. brucei
GCL would be fully functional in vivo without the necessity for
a regulatory subunit.
Recently, GCL from Drosophila melanogaster was cloned by
functional complementation of an S. cerevisiae gsh1 mutant
(10). This was previously called D. melanogaster -glutamyl-
cysteine synthetase, but in the present study, the nomencla-
ture has been changed to DmGCL in accordance with the
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recommendations of IUBMB.2 DmGCL was found to have 57%
amino acid sequence identity to human GCLC, and its expres-
sion in the S. cerevisiae gsh1 mutant partially restored the
glutathione deficiency in this strain. The levels of glutathione
in the complemented yeast strain were, however, only 8% of
those in the parental strain. GCL activity of the expressed
protein was not characterized in that study, but based on the
high level of amino acid sequence identity to human GCLC and
the fact that complementation of the gsh1 mutant resulted in
such a modest restoration of glutathione levels, it seemed to us
highly plausible that DmGCL may require a regulatory sub-
unit for efficient activity in vivo.
The genetic tractability of Drosophila makes it a highly
attractive organism to study the regulation of GCL activity in
vivo. Identification of common regulatory mechanisms for glu-
tathione synthesis in Drosophila and man would make this an
important model to aid our understanding of the functions of
glutathione and the factors that regulate its homeostasis. In
this study, we have identified a candidate GCL regulatory
subunit in Drosophila and demonstrate that it regulates
DmGCL activity in a manner similar, but not identical, to that
of human or rat GCLM.
EXPERIMENTAL PROCEDURES
Construction of DmGCL Constructs—The open reading frame (ORF)
of the gcl gene was amplified from pDmGCS4.3.3 (10) by PCR using
upstream (5-GGGAATTCATATGGGTCTACTGAGCGAGGGC-3) and
downstream (5-GCCTTAACTCGAGTCATTTCTCCTCGCAGCAGCC-
3) oligonucleotides designed to insert EcoRI and NdeI sites at the
5-end and an XhoI site at the 3-end of the ORF. The amplified frag-
ment was cloned into the EcoRI and XhoI sites of pBluescript SK
(Stratagene), whereupon a 1880-bp AccIII/XhoI fragment was replaced
with the corresponding fragment from pDmGCS4.3.3 to minimize the
introduction of PCR errors. Plasmid DNA was isolated, and the insert
was sequenced to confirm that it was identical to the predicted ORF of
pDmGCS4.3.3. The DmGCLC ORF was subcloned into the NdeI and
XhoI sites of pET15b (Novagen) to generate plasmid pETDmGCLC.
The DmGCLM cDNA was obtained as an expressed sequence tag
(GH01757) from ResGen Genomics Resources (a subsidiary of Invitro-
gen), and upstream (5-GGGAATTCCATATGATACCGACCATAACG-
3) and downstream (5-GGAATTCCTCGAGCTAAACGCTCGAC-
CTCG-3) primers were used to amplify the ORF by PCR. The
oligonucleotides were designed to insert EcoRI and NdeI sites at the
5-end and an XhoI site at the 3-end of the ORF. The amplified frag-
ment was subcloned into the EcoRI and XhoI sites of pBluescript SK
and sequenced before subcloning into the NdeI and XhoI sites of
pET15b to generate plasmid pETDmGCLM.
Expression and Purification of Recombinant DmGCL Proteins—pET-
DmGCLC and pETDmGCLM were expressed separately in E. coli
strain BL21(DE3). Transformed cells were grown at 37 °C with shaking
in Terrific Broth (Sigma) containing ampicillin (100 g/ml) to an A600 nm
of 0.5, and protein expression was induced by the addition of isopropyl-
-D-thiogalactopyranoside (1 mM). The temperature was lowered to
30 °C, and growth was allowed to continue for 4 h before harvesting
the cells. Bacterial cell pellets were resuspended in 20 mM Tris-HCl (pH
7.9), 500 mM NaCl, 5 mM imidazole, and 0.1% (v/v) Igepal, and recom-
binant proteins were purified using nickel-agarose chromatography
(QIAGEN Inc.) according to the manufacturer’s instructions.
Gel Filtration Chromatography—Recombinant protein samples were
dialyzed overnight against 3 liters of Buffer A (20 mM Tris-HCl (pH 7.4),
150 mM NaCl, 5 mM L-glutamate, and 5 mM MgCl2) containing 10 mM
glutathione. Protein was precipitated by the addition of ammonium
sulfate to 90% saturation and pelleted by centrifugation. Precipitated
protein was solubilized in 0.5 ml of Buffer A containing 10 mM gluta-
thione and applied to a Sephacryl S-200 16/60 Hi-prep gel filtration
column (Amersham Biosciences, Inc.) pre-equilibrated with Buffer A
containing 0.2 mM dithiothreitol. Gel filtration was carried out by fast
protein liquid chromatography (Amersham Biosciences, Inc.) at a flow
rate of 0.5 ml/min, and fractions were collected at 1-min intervals. The
eluate was monitored by continuous absorption at 280 nm, and protein
concentrations in the eluted fractions were determined by the method of
Bradford (11). The column was calibrated using protein molecular mass
standards (Amersham Biosciences, Inc.).
Analysis of GCL Activity—GCL activity was determined at 25 °C by
a modification of the method of Seelig et al. (12) using cysteine as
substrate instead of L--aminobutyrate and adapted for use on a Cobas
Fara centrifugal analyzer (Roche Molecular Biochemicals, Hertford-
shire, United Kingdom). Reaction mixtures (0.21 ml) contained 10 mM
L-glutamate, 10 mM L-cysteine, 2 mM phosphoenolpyruvate, 0.4 mM
NADH, 1 unit of lactate dehydrogenase, and 1 unit of pyruvate kinase.
The reaction was initiated by the addition of ATP to a final concentra-
tion of 5 mM. Km and Vmax values were determined by measuring initial
reaction rates at glutamate and cysteine concentrations of between 0
and 60 mM. Hyperbolic regression analysis software (43) was used to fit
the Michaelis-Menten parameters using the Hanes plot. For inhibition
studies with L-buthionine-(SR)-sulfoximine (BSO), GCL samples were
incubated at 25 °C with 1.5 M BSO in 100 mM Tris-HCl (pH 8.2), 20 mM
MgCl2, and 5 mM ATP for 10 min prior to kinetic analyses. GCL
inhibition studies with cystamine (2,2-dithiobis(ethylamine)) were per-
formed by incubating GCL samples with 1.5 M cystamine in 100 mM
Tris-HCl (pH 8.2) for 10 min at 25 °C prior to kinetic analyses. For
inhibition studies with glutathione, reduced glutathione was included
in the standard reaction mixture using concentrations of between 0.1
and 10 mM. Inhibition constants were estimated using different concen-
trations of glutathione (0.1, 0.25, and 0.5 mM) with glutamate as the
variable substrate. Nonlinear regression analysis of data was per-
formed using Hyper software (13), and Ki values were estimated using
Enzpack (Biosoft). Lineweaver-Burk plots were used to assess the
mechanisms of inhibition.
S2 Cell Culture—Drosophila S2 cells were a generous gift from Dr.
W. Whitfield (School of Biological Sciences, University of Dundee,
Dundee, UK) and were maintained in serum-free medium (Invitrogen)
routinely supplemented with 2 mM L-glutamine and 5% (v/v) fetal
bovine serum at room temperature.
Cells were seeded 24 h prior to treatment at a density of 1  106
cells/ml and were treated with tert-butylhydroquinone (tBHQ) for 18 h.
tBHQ was prepared as a 100 mM stock in Me2SO and was diluted to the
appropriate concentration in the medium. Control cells were treated
with the equivalent concentration of Me2SO. After treatment, cells were
harvested and resuspended in Buffer B (50 mM Tris-HCl (pH 7.2), 20
mM sodium phosphate buffer (pH 7.0), 150 mM NaCl, and 1% (v/v)
Igepal). Insoluble material was removed by centrifugation, and the
soluble fractions were retained for analysis.
Immunoblotting and Immunoprecipitation—Antisera against puri-
fied recombinant DmGCLC or DmGCLM were raised in sheep using
standard procedures (Scottish Diagnostics, Carluke, UK). Western blot-
ting was performed by the method of Towbin et al. (14), and the even
transfer of samples was ensured by staining with Ponceau S as de-
scribed previously (15). As an additional control for even protein loading
and transfer, blots were also probed with a mouse monoclonal antibody
raised against Drosophila -tubulin (a gift from Dr. W. Whitfield). The
antisera raised against the DmGCL subunits were each used at a
dilution of 1:1000.
For immunoprecipitation experiments, cleared S2 cell lysates (250
l, 0.5 mg/ml protein) were incubated with 50 l of a protein G-agarose
bead slurry (Amersham Biosciences, Inc.) and 1.5 l of anti-DmGCLM
antiserum for 1 h at 4 °C with gentle agitation. The beads were collected
by centrifugation and washed three times with Buffer B, followed by a
single wash with phosphate-buffered saline. Immunoprecipitates were
analyzed by SDS-PAGE and Western blotting.
Statistical Analyses—Statistical analyses were performed using Stu-
dent’s paired t test.
RESULTS
Identification of a Putative DmGCLM Subunit—The amino
acid sequence of DmGCLC is 57% identical to human GCLC.
Phylogenetic alignment of DmGCLC with other GCL sequences
shows that DmGCL has greater identity to mammalian GCL
than to any other GCL subunit so far identified (10). We there-
fore hypothesized that DmGCL may be functionally similar to
mammalian GCL, which requires a modifier subunit for regu-
latable and maximal activity. To test this hypothesis, we
searched the Drosophila genome data base (16) for a GCLM
candidate gene using the human GCLM cDNA sequence as a
probe. The BLAST search identified a single gene within a
bacterial artificial chromosome clone (BACF23F10, Gen-
BankTM/EBI Data Bank accession number AC009846). The2 www.chem.qmw.ac.uk/iubmb/enzyme/EC6/3/2/2.html.
Regulation of Drosophila Glutamate-Cysteine Ligase Activity 1159
cDNA predicted from the genomic sequence encodes a 285-
amino acid polypeptide with an estimated molecular mass of
31.5 kDa. The genomic sequence was used to search the Dro-
sophila expressed sequence tag data base (17), and an ex-
pressed sequence tag (GH01757, accession number AI062531)
with a nucleotide sequence identical to the genomic sequence
was identified. The gene does not appear to have any introns
over this area of the cDNA. Comparison of the predicted amino
acid sequence from the putative DmGCLM cDNA with human
GCLM revealed that the proteins share 27% identity and 42%
similarity. The greatest level of identity is within the C-termi-
nal region (Fig. 1).
Physical Characterization of DmGCL Subunits—The ex-
pressed sequence tag (GH01757) was used as a template to
amplify the ORF of the putative DmGCLM cDNA by PCR. A
single PCR product of 850 bp was obtained and subcloned into
pBluescript SK. The sequence was verified before the insert
was subcloned into pET15b, and the resulting plasmid was
used to express recombinant His-tagged DmGCLM in E. coli as
described under “Experimental Procedures.” Recombinant
DmGCLM was purified from bacterial cell lysates using nickel-
agarose affinity chromatography. Approximately 40 mg of re-
combinant protein was obtained from a 400-ml culture. Anal-
ysis of purified recombinant DmGCLM by SDS-PAGE showed
that it comprises a single polypeptide with an approximate
molecular mass of 31 kDa (data not shown). This is in agree-
ment with the molecular mass calculated from the predicted
amino acid sequence.
The cDNA encoding DmGCLC was isolated recently by func-
tional complementation of an S. cerevisiae GCL mutant (10). In
the present study, the 2160-bp ORF was cloned into pET15b
and used to express DmGCLC as a recombinant His-tagged
protein. This was purified from soluble E. coli extracts using
nickel-agarose affinity chromatography, and 20 mg of DmG-
CLC was obtained from an 800-ml culture. Analysis of purified
recombinant DmGCLC by SDS-PAGE showed that it comprises
a single polypeptide with an approximate molecular mass of 80
kDa (data not shown). This is in good agreement with the
predicted molecular mass of 81 kDa from its amino acid se-
quence (719 amino acids).
The Putative DmGCLM Subunit Interacts with DmGCLC in
Vitro—Human GCLM associates with GCLC to form a holoen-
zyme with an estimated size of 114 kDa (4). To determine
whether the putative DmGCLM subunit identified here asso-
ciates with DmGCLC to form a complex, purified DmGCLM (10
mg of protein) was mixed with DmGCLC (10 mg of protein) and
subjected to gel filtration. The existence of an enzyme complex
should be evident by an increase in the molecular mass of the
eluted protein, relative to DmGCLC or DmGCLM alone.
Analysis of DmGCLC (10 mg of protein) alone by gel filtra-
tion (Fig. 2) revealed that it eluted as a single peak with an
estimated molecular mass of 80 kDa. DmGCLM alone eluted
as a single peak with an estimated molecular mass of 30 kDa
(Fig. 2). Resolution of the DmGCLC/DmGCLM mixture by gel
filtration showed that there was one major protein peak with
an estimated molecular mass of 140 kDa and a minor protein
peak with an estimated molecular mass of 30 kDa correspond-
ing to uncomplexed DmGCLM. From these findings, we con-
cluded that a new protein complex of a higher molecular mass
is generated when DmGCLC and DmGCLM are mixed, infer-
ring that they are interacting with each other in vitro. Enzyme
activity was determined with the fractions collected from gel
filtration of DmGCLC, DmGCLM, or the mixture of DmGCLC
and DmGCLM. Fig. 2B shows that the peaks corresponding to
DmGCLC and the putative DmGCLCDmGCLM complex both
have GCL activity.
To determine the composition of the 140-kDa protein, sam-
ples were analyzed by SDS-PAGE under reducing conditions
and compared with purified DmGCLC and DmGCLM. Fig. 3
shows that polypeptides with molecular masses of 80 kDa
(corresponding to DmGCLC) and 30 kDa (corresponding to
DmGCLM) are present in the 140-kDa protein peak. Reversible
disulfide bridges can form between GCLC and GCLM in the
mammalian holoenzyme (12). To determine whether disulfide
bonds can form between DmGCLM and DmGCLC, we dialyzed
the peak fractions from the 140-kDa complex to remove dithi-
othreitol and subjected the protein to SDS-PAGE analysis un-
der nonreducing conditions (Fig. 3). This showed that a higher
molecular mass complex formed under nonreducing conditions
with an approximate molecular mass of 140 kDa. The 140-kDa
band occurred only when DmGCLC and DmGCLM were to-
gether and was absent when identically treated DmGCLM or
DmGCLC samples were analyzed separately in the same way
(Fig. 3). The 140-kDa band was notably absent in the corre-
sponding samples analyzed under reducing conditions. These
data are therefore highly suggestive that reversible disulfide
linkages are involved in the association of DmGCLC with the
putative DmGCLM subunit.
It is interesting to note that, like the complex eluted from the
gel filtration column, the estimated molecular mass of the
DmGCLCDmGCLM disulfide complex is higher than the ex-
pected 110-kDa size of a homodimer. The estimated molecular
mass of the DmGCL complex is more in keeping with a hetero-
trimeric structure. Molecular mass estimations by gel filtration
FIG. 1. Sequence alignment of DmGCLM with human GCLM. Black boxes show amino acid sequence identity. Gray boxes show amino acid
sequence similarity. The cysteine residues conserved between the Drosophila and human (hGCLM) proteins are indicated with asterisks.
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and SDS-PAGE can, however, be subject to confounding fac-
tors, and further work will be required to determine the sub-
unit stoichiometry of DmGCL.
The DmGCLM Subunit Interacts with DmGCLC in Vivo—To
confirm that DmGCL exists as a complex containing DmGCLC
and DmGCLM in vivo and that our data did not result from an
artifact of in vitro mixing, we determined whether the two
subunits would co-immunoprecipitate from Drosophila S2 cell
extracts. Soluble extracts from S2 cells were incubated with
anti-DmGCLM antiserum and protein G-agarose beads, and
the precipitate was analyzed by Western blotting using anti-
serum raised against DmGCLC. As shown in Fig. 4, a unique
band was identified with an approximate molecular mass of 80
kDa when the immunoprecipitate was probed with antiserum
raised against DmGCLC. This band was absent when the im-
munoprecipitation experiment was performed with the preim-
mune serum. The ability of endogenous DmGCLM to coprecipi-
tate with endogenous DmGCLC from S2 cell extracts implies
that DmGCLM and DmGCLC form a complex in vivo as well as
in vitro.
DmGCLM Modulates DmGCLC Activity—Evidence suggests
that mammalian GCLM can enhance the catalytic efficiency of
GCLC by increasing its affinity for its substrate L-glutamate (1,
2). To determine whether DmGCLM has a similar effect on
DmGCLC activity, we compared the activities of DmGCLC and
the 140-kDa DmGCL holoenzyme after purification by gel
filtration.
DmGCLC and the DmGCL holoenzyme were found to have
specific activities of 244 and 569 nmol/min/mg, respectively
(calculated with respect to the amount of DmGCLC in the
assay mixture) when measured using standard assay condi-
tions with 10 mM L-glutamate. Activity was not detected in the
absence of L-glutamate or L-cysteine. When L--aminobutyrate
was used as substrate in place of cysteine, activity was com-
paratively low, even when high concentrations were used. Km
and Vmax values were determined for L--aminobutyrate, and
the Km was found to be between 4- and 12-fold higher (Table I)
than that reported for human GCL (3, 4). The catalytic effi-
ciency of DmGCL (kcat/Km) with L--aminobutyrate as sub-
strate is 0.53 min1 mM1, implying that L--aminobutyrate is
FIG. 2. Gel filtration of DmGCL sub-
units and the DmGCL holoenzyme.
Recombinant DmGCL holoenzyme was
generated by mixing 10 mg of purified
DmGCLM with 10 mg of DmGCLC and
concentrated by ammonium sulfate pre-
cipitation as described under “Experi-
mental Procedures.” The DmGCL holoen-
zyme () and the uncomplexed DmGCLM
(E) and DmGCLC (Œ) subunits were sep-
arately subjected to gel filtration chroma-
tography. Eluted fractions were analyzed
for protein concentration (A) and GCL ac-
tivity (B).
FIG. 3. Analysis of the subunit composition of the DmGCL
holoenzyme. The peak fractions from gel filtration chromatography of
DmGCLC, DmGCLM, or the DmGCL holoenzyme (2 g of each) were
analyzed by SDS-PAGE in the presence (lanes 2–4) or absence (lanes
6–8) of 2-mercaptoethanol. Lanes 1 and 5, molecular mass markers;
lanes 2 and 6, DmGCLM; lanes 3 and 7, DmGCLC; lanes 4 and 8,
DmGCL holoenzyme.
FIG. 4. Immunoprecipitation of endogenous DmGCLC from S2
cell extracts. Immunoprecipitation of DmGCLM from S2 cell extracts
with antiserum raised against recombinant DmGCLM was performed
as described under “Experimental Procedures.” Immunoprecipitated
proteins were analyzed by Western blotting using antiserum raised
against recombinant DmGCLC. S, supernatant fraction remaining af-
ter immunoprecipitation; IP, immunoprecipitate.
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a poor substrate for DmGCL.
Km and Vmax values for L-glutamate and L-cysteine were
determined. The apparent Km of the DmGCL holoenzyme for
L-glutamate is 0.45 mM, considerably lower than that deter-
mined for DmGCLC, which is 2.88 mM (Table I). Km values for
cysteine were found to be 6.55 and 5.53 mM for the DmGCL
holoenzyme and DmGCLC, respectively. These values are sub-
stantially higher than the corresponding values for human
GCL, for which values of between 0.1 and 0.8 mM have been
reported (3, 4). We also examined the possibility that other
amino acids could substitute for cysteine in the enzyme assay
and tested a range of amino acid substrates, including methi-
onine, alanine, serine, glycine, leucine, and lysine, in place of
cysteine. We were unable to detect any GCL activity over
background levels (data not shown), suggesting that these
amino acids cannot be utilized instead of cysteine by DmGCL.
The kcat/Km values of the holoenzyme for L-cysteine and
L-glutamate are significantly higher than those of DmGCLC
alone (Table I). These findings indicate that the holoenzyme is
catalytically more efficient than DmGCLC and show that
DmGCL is catalytically similar to mammalian GCL in that
GCLM influences GCLC enzyme activity.
DmGCLM Alters the Susceptibility of DmGCLC to Inhibi-
tion—Mammalian GCL activity can be inhibited by glutathione
(2). The nature and extent of inhibition are modulated by the
presence of the regulatory subunit. To determine whether a
similar mechanism of regulation of GCL activity exists for
DmGCL, we first examined the effect of increasing concentra-
tions of glutathione on GCL activity under standard assay
conditions (Fig. 5). DmGCLC activity was reduced by 60% in
the presence of 1 mM glutathione and by 93% in the presence of
2 mM glutathione. By contrast, the holoenzyme was less sus-
ceptible to inhibition by glutathione, with 1 and 2 mM gluta-
thione lowering activity by 32 and 58%, respectively. Higher
concentrations of glutathione (10 mM) almost completely abol-
ished the activities of both DmGCLC and the DmGCL holoen-
zyme. The kinetics of glutathione inhibition were studied by
measuring DmGCL reaction velocities with increasing concen-
trations of glutamate in the presence of fixed glutathione con-
centrations (0.1, 0.25, and 0.5 mM). DmGCLC was inhibited
competitively by glutathione when glutamate was the variable
substrate. By contrast, the holoenzyme was subjected to mixed
inhibition by glutathione. The apparent inhibition constant (Ki)
values for glutathione were 0.03 mM for DmGCLC and 0.67 mM
for the DmGCL holoenzyme (Table I). These findings show that
DmGCLM significantly reduces the sensitivity of the catalytic
subunit to inhibition by glutathione, possibly by generating a
conformational change preventing access of glutathione to the
active site in a manner similar to the model proposed by Mei-
ster and co-workers (2).
BSO is an inhibitor of GCL and is phosphorylated by the
enzyme to form an intermediate that is tightly and irreversibly
bound at the active site (18, 19). It was of interest to examine
the effect of BSO on the DmGCLC subunit and the
DmGCLCDmGCLM complex. Incubation of DmGCLC with 1.5
M BSO for 10 min prior to kinetic analysis caused a 47%
reduction in GCL activity, whereas DmGCL holoenzyme activ-
ity was reduced by 90% (Table II), showing that the
DmGCLCDmGCLM complex is more readily inhibited by BSO
compared with DmGCLC.
Mammalian GCL has also been shown to be susceptible to
inhibition by cystamine, which is thought to inhibit GCL activ-
ity by binding a cysteine residue in or around the active site
(20–22). Inhibition can be reversed by treatment with dithio-
threitol. Incubation of DmGCLC for 10 min prior to kinetic
analysis with 1.5 M cystamine reduced DmGCLC activity by
34%, suggesting that the DmGCLC active site may be struc-
turally similar to mammalian GCL with a cysteine residue
near the active site (Table II). Curiously, the DmGCL holoen-
zyme was unaffected by the presence of 1.5 M cystamine. It is
possible that free thiol groups on the DmGCLM subunit may
preferentially form disulfides with cystamine, sparing the cys-
teine that is close to the active site. This raises the possibility
that the GCL regulatory subunit may have an additional func-
tion to protect the catalytic subunit from thiol-reactive agents.
DmGCL Subunit Levels Are Modulated by Oxidative Stress
in S2 Cells—GCLC and GCLM protein levels have been shown
to increase in response to agents capable of generating suble-
thal oxidative stress in human cell lines (23–25). We wished to
determine whether induction of the DmGCL subunits consti-
tutes part of the adaptive response to oxidative stress in Dro-
sophila and treated S2 cells with the redox cycling agent tBHQ
to examine this possibility.
Western blot analyses of S2 cells treated with increasing
concentrations of tBHQ showed that tBHQ caused a concentra-
tion-dependent increase in intracellular DmGCLC protein lev-
FIG. 5. Inhibition of recombinant DmGCL activity by glutathi-
one. The specific activities of the DmGCL holoenzyme () and DmG-
CLC (E) were measured using standard assay conditions in the pres-
ence of increasing concentrations of glutathione. Activity is expressed
as a percentage of the control activity in the absence of glutathione
(mean  S.E.).
TABLE I
Kinetic constants for Drosophila GCL
Kinetic constants for DmGCL are compared with those for DmGCLC and were analyzed using Student’s paired t test. AB, L--aminobutyrate.
Enzyme
Km kcat/Km Ki for
glutathione
L-Glu L-Cys AB L-Glu L-Cys AB
mM min1 mM1 mM
DmGCLC 2.88  0.08 5.53  0.72 12.35  4.13 5.62  0.29 3.07  0.22 0.26  0.07 0.03  0.01
DmGCL 0.45  0.02a 6.55  0.41 13.03  2.94 100.08  2.38a 9.94  0.24a 0.53  0.1 0.67  0.33a
a Significant differences (p  0.05).
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els (Fig. 6A). Treatment with 50 or 100 M tBHQ caused
increases in DmGCLC of 3- and 4-fold, respectively. By con-
trast, DmGCLM protein levels did not appear to be substan-
tially increased by treatment with tBHQ (Fig. 6B).
DISCUSSION
GCL activity in mammals is subject to intricate regulation
involving both post-translational and transcriptional control
mechanisms (19). It was unknown whether these regulatory
features are conserved in invertebrates, and in this study, we
have demonstrated a parallelism in the regulation of GCL
activity in mammals and Drosophila. We have shown that
DmGCL is composed of a catalytic subunit and at least one
regulatory subunit that enhances the affinity of DmGCLC for
glutamate and reduces its susceptibility to inhibition by gluta-
thione. Furthermore, as has been shown for human GCLC,
DmGCLC protein levels can be up-regulated in cell lines by
agents that generate oxidative stress.
Non-mammalian GCL has been described for a wide variety
of eukaryotic species, including yeast, Nematoda, Protozoa,
and Insecta, and has been isolated as a single chain polypeptide
with similarity to human GCL (6–8, 10, 26–28). By contrast,
Arabidopsis thaliana GCL has no significant identity (15–19%)
to other GCL forms (29, 30). Until now, functional non-mam-
malian GCLM homologs have not been described in the litera-
ture. It has been suggested that certain lower eukaryotic spe-
cies do not require a GCLM subunit, as enzyme kinetic studies
showed that they are likely to be active in vivo without the
requirement for a regulatory subunit (8). The lack of documen-
tation about GCLM homologs in lower eukaryotes does not,
however, confirm that they are absent. It is possible that, in
certain lower eukaryotes, GCL enzymes contain functional
GCLM subunits, but their presence has been overlooked due to
the method of GCL isolation. Very few GCL enzymes have been
isolated from invertebrates by purification of native proteins.
Instead, direct cloning or functional complementation of mu-
tants has been used to identify cDNAs encoding proteins with
GCL activity. As GCLM is not required for activity in vitro, a
requirement for its presence in vivo may not have been noted.
The possibility that GCL may comprise catalytic and modifier
polypeptides in invertebrates other than Drosophila is
strengthened by work by Hussein and Walter (31), who purified
GCL from the nematode Ascaris suum. Purification of A. suum
GCL by gel filtration showed the presence of two protein peaks
with GCL activity with molecular masses of 100 and 70 kDa.
Although the 100-kDa protein was not characterized, the pos-
sibility that it contains catalytic and regulatory subunits would
be interesting to investigate further.
Although we have raised the possibility that GCL may com-
prise catalytic and regulatory subunits in other invertebrates,
we do not suggest that this would necessarily occur in all cases.
Indeed, GCL from T. brucei has a Km for glutamate of 0.24 mM
and a Ki for glutathione of 1.1 mM, which are similar to those
obtained for the DmGCLCDmGCLM complex. The kinetics of
T. brucei GCL activity suggest that it may not require further
activation by a GCLM subunit (8). It remains to be determined
whether the regulation of GCL activity by a modifier subunit is
a common feature in different invertebrates and when, in evo-
lutionary terms, it became an important regulator of glutathi-
one synthesis.
DmGCLM reduces the Km of DmGCLC for glutamate and
raises the Ki for glutathione in a manner similar to that of its
mammalian counterparts. GCLM-mediated changes in the ki-
netic efficiency of mammalian GCLC are thought to be due to a
conformational change in GCLC favoring a glutamate-binding
site with high affinity and specificity for L-glutamate; the high
affinity glutamate-binding site is also less accessible to gluta-
thione (2). This conformational change is thought to result, in
part, from the formation of intersubunit disulfide bridges be-
tween GCLM and GCLC. These covalent linkages are suscep-
tible to changes in the reducing environment and are proposed
to modify GCL activity in response to changes in intracellular
glutathione concentrations (2). Our kinetic studies on inhibi-
tion of DmGCL by glutathione show that similar regulatory
mechanisms for GCL activity may exist in Drosophila. DmG-
CLC inhibition by glutathione is competitive with respect to
glutamate, whereas inhibition of the holoenzyme by glutathi-
one can be classed as mixed. These findings are in keeping with
the hypothesis that reduction of disulfide bridges between
DmGCLC and DmGCLM by glutathione facilitates access of
glutathione to the active site, where it could compete with
glutamate. When DmGCLM is absent, the active site of DmG-
CLC appears to be accessible for competitive inhibition by
glutathione. Our hypothesis that inhibition of the DmGCL
holoenzyme by glutathione is likely to involve reduction of
disulfide linkages between the subunits is supported by the
demonstration that the DmGCLCDmGCLM complex can form
reversible disulfide linkages when subjected to SDS-PAGE un-
der nonreducing conditions (Fig. 3). Comparison of the amino
acid sequences of DmGCLM and human GCLM shows that
there are two conserved cysteine residues (Fig. 1, asterisks). It
is possible that one or both of these residues mediate the
covalent interactions with DmGCLC, and we are currently
investigating this further.
In addition to examining the effect of the modifier subunit on
the catalytic efficiency of GCLC and its inhibition by glutathi-
one, we also investigated whether GCLM influenced suscepti-
bility to inhibition by BSO or cystamine. DmGCLM appears to
protect DmGCLC against inhibition by cystamine, as DmGCLC
was inhibited by cystamine, whereas the DmGCL holoenzyme
was unaffected under the assay conditions used. The mecha-
TABLE II
Effect of BSO or cystamine on DmGCL activity
The specific activities in the presence of BSO or cystamine are com-
pared with the appropriate control activities and were analyzed using
Student’s paired t test.
Enzyme
Activity
No
inhibitor 1.5 M BSO 1.5 M cystamine
% control
DmGCLC 100 53.32  0.55a 66.27  0.32a
DmGCL 100 9.63  0.9a 98.90  0.75
a Significant differences (p  0.05).
FIG. 6. Effect of tBHQ on DmGCL subunit levels in S2 cells. S2
cells were cultured in the presence of tBHQ for 18 h, and cell lysates (30
g of protein) were analyzed by Western blotting using antibodies
raised against DmGCLC (A), DmGCLM (B), or Drosophila -tubulin
(C). The lanes were loaded with extracts from cells that had been
treated as follows. Lane 1, no treatment; lane 2, Me2SO; lane 3, 25 M
tBHQ; lane 4, 50 M tBHQ; lane 5, 75 M tBHQ; lane 6, 100 M tBHQ.
The relative intensities of cross-reactive bands were examined by scan-
ning densitometry.
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nism for this protection is unclear, but it is possibly due to
DmGCLM buffering the local cystamine concentrations by pro-
viding additional thiol-binding sites. Cystamine forms mixed
disulfides with GCLC and binds a cysteine residue close to the
active site, blocking substrate access (9, 21). It is possible that
surface sulfhydryl residues on DmGCLM become preferentially
bound by cystamine, thus protecting a critical cysteine at or
near the active site of DmGCLC. By contrast, the DmGCL
holoenzyme was found to be more sensitive to inhibition by
BSO compared with DmGCLC. It has been shown that phos-
phorylation of BSO by GCL generates an intermediate that
binds tightly and irreversibly to the glutamate- and cysteine-
binding sites of GCL (32). Although we have not investigated
the mechanism for the differential inhibition by BSO, it is
possible that the conformational change imposed upon the ac-
tive site of DmGCLC by DmGCLM generates a binding pocket
with greater affinity for BSO, thus making it a more potent
inhibitor for the holoenzyme than the catalytic subunit alone.
Alternatively, as BSO is a time-dependent inhibitor, the differ-
ential inhibition could reflect an increase in the rate of BSO
phosphorylation in the presence of the regulatory subunit.
The apparent size of the DmGCL holoenzyme complex ap-
pears to be larger than that described for rat or human GCL.
We estimate the DmGCL complex formed in vitro to be 140
kDa. This suggests that the reconstituted DmGCL holoenzyme
may, in fact, comprise one catalytic subunit and two regulatory
subunits. Studies with GCL from rat kidney led Sekura and
Meister (33) and Seelig et al. (12) to suggest that it exists as a
heterodimer. Other studies with recombinant human GCL are
also consistent with a heterodimeric structure (3, 4). It has,
however, been documented that the amount of GCLM associ-
ated with GCLC may vary between different enzyme prepara-
tions (34). Interestingly, GCL purified from rat liver by Davis et
al. (35) was estimated by gel filtration to be 138 kDa, which
would be consistent with a heterotrimeric structure. It is pos-
sible that the molar ratios of the catalytic and modifier sub-
units may be subject to a degree of variation in vivo.
Elevated intracellular glutathione levels and glutathione-
metabolizing enzymes have been observed in mammalian cells
and yeast as part of an adaptive response to oxidative stress
(23, 24). Glutathione-depleting agents, heavy metals, redox
cycling chemicals, inflammatory cytokines, chemotherapeutic
drugs, and ionizing radiation have been shown to modify intra-
cellular glutathione and GCL protein levels. This appears to be
due to induction of GCL transcription as well as mRNA stabi-
lization. The redox cycling agent tBHQ has been used in many
mammalian cell lines to generate oxidative stress and has been
shown to elevate GCL subunit mRNA levels by increasing gene
transcription, leading to increased GCL protein levels, GCL
activity, and elevated glutathione levels (23, 24). In this study,
we found that DmGCLC protein levels were up-regulated in
Drosophila S2 cells in response to tBHQ. Although we did not
determine whether transcriptional activation of DmGCLC
mRNA occurred in this study, it is likely that the elevation of
DmGCLC protein levels reflects increased DmGCLC gene tran-
scription. We have identified several putative enhancer ele-
ments in the genomic DNA sequence (16) upstream from the
DmGCLC ORF. These include AP-1- and nuclear factor-B-
binding sites and could potentially be involved in increasing
DmGCLC transcription in response to tBHQ. Oxidative stress
is thought to induce transcription of mammalian glutathione-
associated genes by triggering signaling cascades that activate
various transcription factors such as Nrf2, AP-1, and nuclear
factor-B. Homologs of mammalian c-Jun and c-Fos as well as
nuclear factor-B exist in Drosophila (D-Jun, D-Fos, and the
Rel family, respectively) (36, 37), but their role in adaptation to
oxidative stress within Drosophila has not, to our knowledge,
been characterized as rigorously as that of their mammalian
counterparts.
In contrast to our findings for DmGCLC, DmGCLM protein
levels were only marginally enhanced in response to tBHQ
treatment. In mammals and mammalian systems, GCLC and
GCLM are also subject to a degree of differential regulation,
although both subunits are usually increased in response to
oxidative stress (23, 24).
As has been shown for the human and mouse GCL genes
(38), the DmGCL genes are on separate chromosomes. The
DmGCLC gene is on the X chromosome (polytene map position
7CD) (10), whereas the DmGCLM gene maps to 94C on the
third chromosome. One of the advantages of working with the
Drosophila system is the existence of mutant stocks created by
P-element mobilization (39, 40). Stocks are often in existence
with mutations in or near the gene of interest. We have ob-
tained the P-element-induced recessive lethal l(3)L0580, which
contains a P-element insertion in the 5-noncoding region of the
DmGCLM gene. Although we have yet to establish that the
P-element insertion is responsible for the lethality, there is a
good possibility that DmGCLM is essential for glutathione
synthesis in vivo, as proposed by Meister and co-workers (1) for
rat GCL from their in vitro studies. Targeted deletion of the
GCLC gene in the mouse is lethal, showing that glutathione is
essential for normal embryonic development (41, 42). To date,
corresponding models for the GCLM gene have not been de-
scribed. If, as we suspect, loss of DmGCLM gene function is
lethal, mutants will provide valuable genetic models with
which to study the regulation of GCL activity in vivo.
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